BOUNDLESS BIO, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | $-81.7M | $11.5M |
| Mar 2023 | — | $-92.4M | $21.1M |
| Jun 2023 | — | $-103.9M | $41.3M |
| Sep 2023 | — | $-116.0M | $21.0M |
| Dec 2023 | — | $-127.1M | $23.7M |
| Mar 2024 | — | $-141.2M | $25.1M |
| Jun 2024 | — | $179.2M | $31.4M |
| Sep 2024 | — | $165.1M | $40.2M |
| Dec 2024 | — | $150.6M | $26.6M |
| Mar 2025 | — | $136.6M | $15.1M |
| Jun 2025 | — | $122.7M | $14.7M |
| Sep 2025 | — | $110.2M | $15.0M |
| Dec 2025 | — | $98.7M | $17.9M |
| Mar 2026 | — | $86.4M | $17.5M |
| Jun 2026 | — | $66.0M | $20.2M |